Dr Reddy's Laboratories Ltd ADR

RDY: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|.>lLOCK|%GLOCK|Y<Ty<F

Dr. Reddy's Earnings: Good Start to Year as Healthy International Numbers Offset Lenalidomide Impact

Dr. Reddy's fiscal first-quarter results were highlighted by 11% revenue growth and a 2% increase in EPS. Both figures trailed FactSet estimates, which suggested 13% and 10% growth, respectively.

Sponsor Center